Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals The Watchlist 20 September 2024

Actinogen Medical (ASX:ACW) is developing a promising oral treatment for Alzheimer’s and depression and is accelerating clinical trials with new capital. CEO Steven Gourlay, joins The Market Onlineto discuss the company’s development.